- Institution
- 경기도 광주시
- Department
- 감염병관리과
○감염병 등 진단검사비 지원 경정 909,000원
Programme 검사업무관리
Amounts and period
- Budgeted amount
- 909,000 KRW
- 기정액
- 5,000,000 KRW
- Change
- −4,091,000 KRW −81.8%
Programme hierarchy and share
The selected item’s share of each parent budget, calculated from amounts in the same source document.
A share is not calculated for missing or partial amounts, non-positive parent amounts, or an item amount greater than its parent.
-
Department 감염병관리과 25,506,909,000 KRW0.0%
-
Policy 지역보건 의료서비스 제공 24,232,944,000 KRW0.0%
-
Programme 감염병관리사업 10,334,532,000 KRW0.0%
-
Project 검사업무관리 422,808,000 KRW0.2%
-
Budget category 일반운영비 128,163,000 KRW0.7%
-
Statistical item 사무관리비 123,163,000 KRW0.7%
-
Item ○감염병 등 진단검사비 지원 경정 909,000원 909,000 KRW
- Category–statistical code
- 201-01
- Group
- Not provided in source
Original description
Not provided in source
Institution and programme names are shown as the original Korean source text.
Detailed budget items
3 itemsData source
-
Open source PDF
경기도 광주시 · FY2022 3회 추경 · 통합회계 · 2022년 제3회 일반 및 기타 특별회계 추가경정예산서
Opens in a new window
- Page
- 331 / 430
View source document details
- Document ID
doc_4h01qkgjq6w4wz2fwq7typ94mx- Source document status
- Available
- File type
- application/pdf
- File size
- 3,148.481 KiB
- Location inside the source
- Page 331 Row 23 Line 3 Column level4
Source and reference
FY 2022 release No source record
- Fiscal year of record
- 2022
- Fetched from the source
- 2026-07-29 20:19
- Read and interpreted
- 2026-07-29 20:19
- Query snapshot refreshed
- 2026-09-02 03:23
- Item ID
bi_5p1cp0bty184qt3qyhf8rhwq1n- Address of this item
- /en/BudgetDetail/Item/bi_5p1cp0bty184qt3qyhf8rhwq1n
Related records
Similar budgets
3 itemsItems share the same budget classification and a related name. Different years may be included. The name search uses the keyword without a classification filter.
Keyword “진단검사비” · classification 201-01
These items were verified within a limited set of name search results.
AI analysis report
AI analysis reports are not yet available.